EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 26-Oct-2026 02:17 ET (26-Oct-2026 06:17 GMT/UTC)

The Lancet: Bloodstream-delivered cell therapy slows muscle decline in young people with Duchenne muscular dystrophy, phase 3 trial finds

The Lancet
Peer-Reviewed Publication

A cell therapy called deramiocel could slow muscle weakening in boys and young men with advanced Duchenne muscular dystrophy (DMD), and may also slow heart damage in those who already have heart muscle disease, a phase 3 clinical trial published in The Lancet has found. It is the first phase 3 trial of a cell therapy made from donor cells and administered through the bloodstream to treat a genetic disease, and the first such trial in boys and young men whose DMD is already advanced. The therapy is grown from heart cells that were donated for transplant but could not be used.

Journal: The Lancet

Widening inequalities in stroke identified in 30-year research

King's College London
Peer-Reviewed Publication

The prevalence of stroke risk factors such as high blood pressure and diabetes are higher and increasing faster among black African and Caribbean groups, compared to people from white backgrounds.

Journal: EClinicalMedicine

JMIR Pediatrics and Parenting invites submissions on Algorithmic Parenting: The Rise of Data-Driven Child-Rearing

JMIR Publications
Business Announcement

JMIR Publications invites submissions to a new section on “Algorithmic Parenting: The Rise of Data-Driven Child-Rearing” in its open access journal JMIR Pediatrics and Parenting.

Biofilm clue opens route to anti-infection treatments of the future

John Innes Centre
Peer-Reviewed Publication

A multidisciplinary study has uncovered a critical component in the formation of biofilms, the complex structures used by bacteria to colonise surfaces. The research may have implications for future infection treatments, including for people with cystic fibrosis.

Journal: PLOS Pathogens
Funder: UKRI/BBSRC

Sensing-storage monolithically integrated system for wearable physiological sensing

Tsinghua University Press
Peer-Reviewed Publication

A flexible sensing-storage integrated system have been developed for wearable health monitoring. This system is fabricated using a low-cost solution spin-coating process, combining a flexible floating-gate organic thin-film transistor memory with an organic thin-film transistor pressure sensor to achieve in-situ acquisition and storage of physiological signals, which provides an innovative platform for constructing low-cost, fully flexible electronic skins capable of simultaneous physiological sensing, data storage, and wireless transmission.

Journal: Nano Research

American College of Lifestyle Medicine announces call to action to advance remission as a clinical goal for chronic disease

American College of Lifestyle Medicine
Business Announcement

The project highlights evidence and practical applications related to conditions that often share common underlying drivers, including type 2 diabetes, hypertension and obesity.

Insilico Medicine receives FDA Fast Track Designation for ISM6331, the AI-driven Pan-TEAD Inhibitor, in advanced mesothelioma

InSilico Medicine
Business Announcement

FDA Fast Track Designation (FTD) aims to accelerate the review process of high-value assets, and ISM6331 marks Insilico’s first FTD, recognizing the clinical potential in advanced mesothelioma.

ISM6331 is a novel, potential best-in-class, pan-TEAD inhibitor engineered via Chemistry42 to restore Hippo pathway balance, and its Phase I first-in-human data has been accepted for a brief oral presentation at ESMO 2026.

The FTD grants ISM6331 enhanced FDA engagement to accelerate the clinical development processes, alongside eligibility for Rolling Review, Accelerated Approval, and Priority Review, if relevant criteria are met.

Inflammation may drive Dravet syndrome, offering a potential new treatment target

Weill Cornell Medicine
Peer-Reviewed Publication

An overactive immune response in the brain may play a role in Dravet Syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers. Children with the condition experience frequent seizures that are often difficult to control with medication and may also face developmental, cognitive and behavioral challenges. Until now, most research has focused on how a mutation in the SCN1A gene disrupts electrical signaling in the brain.

Journal: Nature Neuroscience

Frontiers in Science Deep Dive webinar series: Simple test could help track metabolic health in cancer and chronic disease

Frontiers
Meeting Announcement

Discover how the glucose ketone index (GKI) could help researchers and clinicians better understand metabolic health and support the management and prevention of chronic noncommunicable diseases (NCDs) worldwide.